• Politics
  • Business
  • World
  • Science
  • Startup
  • Health
  • Travel
  • Economy
  • Top Story
Aryavarth News
  • Home
  • Politics
  • City News
  • Top Story
  • Editorial
No Result
View All Result
Aryavarth News
No Result
View All Result

2nd Made-in-India vax coming, deal signed for 30 cr doses

Biological-E's vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2, and it is likely to be available in the market in next few months, said a Ministry of Health and Family Welfare (MoHFW) statement.

2nd Made-in-India vax coming, deal signed for 30 cr doses
98
SHARES
247
VIEWS
Share on WhatsappShare on FacebookShare on TwitterShare on Telegram

New Delhi,(Aryavarth) In another landmark move in the fight against Covid-19 pandemic, the Central government has booked 30 crore doses of another Made-in-India vaccine to be manufactured by Hyderabad-based Biological-E’s Covid vaccine, which is still in final phase of clinical trials.

Biological-E’s vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2, and it is likely to be available in the market in next few months, said a Ministry of Health and Family Welfare (MoHFW) statement.

The Ministry is learnt to have made an advance payment of Rs 1,500 crore to the firm — the second made-in-India vaccine manufacturer after Bharat Biotech’s Covaxin.

“The doses will be manufactured and stockpiled by Biological-E from August to December and is likely to be available “in the next few months,” the Ministry said.

The move is expected to be a sigh of relief for the Centre facing wide criticism amid shortage of Covid vaccine during the second wave of the pandemic.

Biological-E’s shot, the Ministry said, was given Rs 100 crore in financial assistance by the Department of Biotechnology, which also partnered with the company to conduct various studies.

This is part of the government’s mission to support five or six new COVID-19 vaccine candidates, said the statement.

Biological-E’s indigenous vaccine was recommended for approval by the National Expert Group on Vaccine Administration for Covid-19 or National Expert Group on Vaccine Administration for Covid-19.

Biological-E also has a separate deal to produce about 600 million doses of Johnson and Johnson’s Covid-19 shot annually. The company said on Tuesday it entered into a licensing agreement with Providence Therapeutics Holdings to manufacture mRNA Covid-19 vaccines in India.

Besides Covaxin and Serum Institute of India’s Covishield, Russia’s Sputnik V will soon be used to vaccinate people as the government races towards a target of one crore vaccinations a day by August. It is also in talks with foreign makers like Pfizer and Moderna, who have insisted on an indemnity clause.

The new vaccine arrangement is “part of the wider endeavour of the government to encourage indigenous vaccine manufacturers” by providing them support in research and development and costs, the Centre said.

Tags: #covidvaccine
SendShare34Tweet22Share
    • Trending
    • Comments
    • Latest
    Guru Gobinds son bricked alive and then killed

    Crores of Hindus Were killed by Islamic Rulers: Hindu Genocide Not Recorded In History

    August 10, 2020
    Pakistan Behind removal of Punjab CM:  Dr Subramanian Swamy

    Pakistan Behind removal of Punjab CM: Dr Subramanian Swamy

    September 20, 2021
    Lenovo under US scanner for spying for China

    Lenovo’s Links to China Government Under Scrutiny For Spying

    July 22, 2020
    Republic TV and R Bharat get a clean chit in Television Rating Points (TRP) scam

    Republic TV and R Bharat get a clean chit in Television Rating Points (TRP) scam

    3
    Today’s Newspaper – 17 August 2022

    Today’s Newspaper – 17 August 2022

    2
    Today’s Newspaper – 10 August 2022

    Today’s Newspaper – 10 August 2022

    1
    WHO and the Ministry of Ayush to host the first-ever Global Summit on Traditional Medicine

    Only Positive Step In G20 Summit Was The Admission Of African Union As A Permanent Member

    September 15, 2023
    Singapore invents tech to detect COVID-19 virus the air

    India Rises as Global Leader in Medical Textiles Amid COVID-19 Pandemic

    September 15, 2023
    Improving Healthcare for All

    CSIR-NIScPR and KAMP Host Workshop to Boost Science Communication in India

    September 15, 2023
    Aryavarth News

    Copyright © 2022 Aryavarth Publication Pvt Ltd.

    Navigate Site

    • About
    • Advertise
    • Privacy & Policy
    • Contact

    Follow Us

    No Result
    View All Result
    • Politics
    • Business
    • World
    • Science
    • Startup
    • Health
    • Travel
    • Economy
    • Top Story

    Copyright © 2022 Aryavarth Publication Pvt Ltd.

    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.